BioLineRx (BLRX) Short-term Investments (2023 - 2025)
Historic Short-term Investments for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $17.3 million.
- BioLineRx's Short-term Investments fell 1494.32% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 1494.32%. This contributed to the annual value of $9.1 million for FY2024, which is 7644.23% down from last year.
- Per BioLineRx's latest filing, its Short-term Investments stood at $17.3 million for Q3 2025, which was down 1494.32% from $21.0 million recorded in Q2 2025.
- In the past 5 years, BioLineRx's Short-term Investments registered a high of $38.7 million during Q4 2023, and its lowest value of $9.1 million during Q4 2024.
- Over the past 3 years, BioLineRx's median Short-term Investments value was $21.0 million (recorded in 2025), while the average stood at $22.9 million.
- Within the past 5 years, the most significant YoY rise in BioLineRx's Short-term Investments was 3401.88% (2024), while the steepest drop was 7644.23% (2024).
- BioLineRx's Short-term Investments (Quarter) stood at $38.7 million in 2023, then plummeted by 76.44% to $9.1 million in 2024, then skyrocketed by 89.55% to $17.3 million in 2025.
- Its Short-term Investments was $17.3 million in Q3 2025, compared to $21.0 million in Q2 2025 and $17.3 million in Q1 2025.